Seeking Solutions for Brain Tumors
Qualify for a free subscription to HealthLeaders magazine.
“We’re not in the top ranking among [hospitals conducting] clinical trials, but when you look at enrollment we are at the top of the list,” he says. “We are offering a high volume of cases, and the more you do, the
better you are; like in many disciplines, it relates to better outcomes and
Researching a prospective “tumor vaccine is something we are pursuing,” he says. In developing programs, whether telestroke or brain tumor research, “having clinical focus is absolutely critical,” Pomeroy says.
Funding sources for the Barrow programs include the National Institutes of Health, focusing on areas ranging from basic science research, advanced diagnostics, or therapeutic innovations. “I think increasing our clinical volume will be a substantial indicator of our success,” Pomeroy says.
Joe Cantlupe is a senior editor with HealthLeaders Media Online.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- Drug Pricing 'Tantamount to Greed,' Lawmaker Says
- Study Puts Spotlight on Preventing Fall-Related Injuries
- Wanted: Nurse PhDs
- Contradictory Obamacare Rulings Issued by Appellate Courts
- The Infection-Busting Treatment Payers Don’t Want to Talk About
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- 4 Tectonic Shifts Shaking Up Healthcare
- As HIPAA Breaches Accelerate, Tools Lag
- Ascension, Carondelet to Partner with Tenet, Dignity Health